ALPS Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
34,178
-12,029
| -26% | -$760K | 0.01% | 357 |
|
|
2025
Q1 | $2.45M | Sell |
46,207
-3,493
| -7% | -$185K | 0.01% | 318 |
|
|
2024
Q4 | $2.78M | Buy |
+49,700
| New | +$2.78M | 0.02% | 300 |
|
|
2024
Q2 | – | Sell |
-42,419
| Closed | -$1.84M | – | 995 |
|
|
2024
Q1 | $1.84M | Buy |
42,419
+2,204
| +5% | +$95.5K | 0.01% | 368 |
|
|
2023
Q4 | $1.85M | Sell |
40,215
-1,736
| -4% | -$79.8K | 0.01% | 343 |
|
|
2023
Q3 | $962K | Buy |
41,951
+158
| +0.4% | +$3.62K | 0.01% | 464 |
|
|
2023
Q2 | $689K | Buy |
41,793
+4,405
| +12% | +$72.6K | 0.01% | 557 |
|
|
2023
Q1 | $667K | Sell |
37,388
-810
| -2% | -$14.5K | 0.01% | 537 |
|
|
2022
Q4 | $1.11M | Buy |
+38,198
| New | +$1.11M | 0.01% | 442 |
|
|
2019
Q4 | – | Sell |
-68,850
| Closed | -$1.49M | – | 855 |
|
|
2019
Q3 | $1.49M | Sell |
68,850
-3,220
| -4% | -$69.5K | 0.01% | 247 |
|
|
2019
Q2 | $1.59M | Sell |
72,070
-11,045
| -13% | -$243K | 0.01% | 258 |
|
|
2019
Q1 | $2.28M | Buy |
83,115
+3,594
| +5% | +$98.5K | 0.02% | 211 |
|
|
2018
Q4 | $2.14M | Buy |
79,521
+19,045
| +31% | +$512K | 0.02% | 213 |
|
|
2018
Q3 | $1.76M | Buy |
60,476
+20,524
| +51% | +$599K | 0.01% | 268 |
|
|
2018
Q2 | $1.25M | Buy |
39,952
+3,359
| +9% | +$105K | 0.01% | 295 |
|
|
2018
Q1 | $728K | Buy |
+36,593
| New | +$728K | 0.01% | 371 |
|